In a letter to Congressman Mark Meadows, CBO explains its estimate for section 53116 of the Bipartisan Budget Act requiring brand-name prescription drug manufacturers to increase the discount offered to some Medicare Part D beneficiaries.
In a letter to Congressman Mark Meadows, CBO explains its estimate for section 53116 of the Bipartisan Budget Act requiring brand-name prescription drug manufacturers to increase the discount offered to some Medicare Part D beneficiaries.
CBO provides additional information to Congressman Mark Meadows about the budgetary treatment of the government’s payments to reimburse health care insurers for cost-sharing reductions they provide to eligible people.
